P2X7 Reseptörü Aracılı Hücre Membran Geçirgenlik Artıșı P2X7
Abstract
Purinergic receptors consist of two main families; P2X and P2Y. P2Y receptors are G protein coupled receptors (GPCR), whereas P2X receptors are non-selective cation channels. P2X7 receptors which is a member of P2X receptors, have been found myriad types of cells including immune cells. The activation of this receptor leads to IL-1β release and caspase activation as well as an increase in membranepermeability to big molecules. Spectroscopic and electrophysiologic methods have been used to investigate membrane permeability. Different hypotheses have been proposed as an explanation for big permeability. One of them proposes that P2X7 channel itself dilates and becomes permeable to big molecules, whereas the other proposes participation of another channels to big permeability. Since it has been demonstrated that P2X7 receptor has a role in many disease processes including inflamation, pain, cancer and Alzheimer’s disease, its antagonists and modulators have been regarded as a good drug target. The uncovering of its activation mechanism is important for treatment of many diseases.
Keywords
P2X7 Receptor, Membrane Permeability, YoPro-1, Lucifer Yellow
References
- 1. Burnstock G, Campbell G, Satchell D, et al. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol. 1970; 40:668–688.
- 2. Schwiebert EM, Zsembery A, Geibely JP. Cellular Mechanisms and Physiology of Nucleotide and Nucleoside Release from Cells: Current Knowledge, Novel Assays to Detect Purinergic Agonists, and Future Directions. Current Topics in Membranes. 2003; Volume 54:31-58
- 3. Burnstock G. Introduction and perspective, historical note. Front Cell Neurosci. 2013;7:1-13
- 4. Ivar von Kügelgen. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Biotrend Reviews. 2008; 9:1-12
- 5. North RA ve Barnard EA. Nucleotide receptors. Curr Opin Neurobiol. 1997; Jun 110(3):415-32
- 6. Surprenant A ve North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol. 2009; 71:333-59
- 7. Burnstock G. Purinergic signalling: from discovery to current developments. Exp Physiol. 2014; 99(1):16-34
- 8. Surprenant A, Rassendren F, Kawashima E et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 1996; 272: 735–738.
- 9. Bartlett R, Stokes L, Sluyter R. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev. 2014; 66(3):638-75.
- 10. Jacobson KA, Müller CE. Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology. 2016; May 104:31-49.